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between the nature of the brain damage in
the aging process (in the case of dementia
or even in outwardly healthy elderly peo-
ple) and the brain damage caused by prion
diseases of humans and animals (Sobel,
1970; Fraser and McBride, 1985; Masters
et al., 1985; Gajdusek, 1988). In both cases,
lesions are characterized by the two fun-
damental processes—the loss of neurons
and an active proliferation of glial cells—
gliosis (Finch, 2002; Kim and de Vellis,
2005; Deng et al., 2006; Bessis et al., 2007).
In case of prion diseases, neuronal cell
death was originally coupled with the
action of an infectious agent, while gliosis
was always considered only as a reparative
response of glial cells to the destruction of
neurons (Brown, 1997; Ironside and Bell,
1997; Finch, 2002). However, an infectious
agent is absent in the aging process, so
the reason for the primary neuronal cell
death is also absent. These arguments led
us to a basic hypothesis about the pri-
mary role of gliosis in the development
of the aging process, which, as we sup-
posed, results in the death of neurons. We
assumed that the distribution of glial ele-
ments in the confined space could easily
disturb the nutrition of the neuron (Zuev,
2001). Indeed, the interaction between a
neuron and a brain capillary is not direct
and is realized through an intermediary,
the astrocyte, rather than through its (neu-
ron) close proximity to the wall of the
capillary (Magistretti et al., 1999). It is also
known that this liaison is not sufficiently
strong (Cotrina and Nedergaard, 2002).
Therefore, all of this allows us to suppose
that an active reproduction of the sur-
rounding glial cells may be quite sufficient
to break this fragile relationship between
an astrocyte and a neuron, on the one
hand, and an astrocyte and a capillary, on
the other hand, which will eventually lead
a neuronal cell to “starve to death.”
It is possible that in order to trigger
the process of active cell proliferation in
the course of aging, a specific factor (“the
aging factor”), which will stimulate this
active proliferation of glial cells, needs to
be accumulated in the brain tissue. In
order to find this factor of aging, we con-
ducted the experiments described below.
The first series of experiments were
aimed at determining the stimulating
effect of the brain extracts obtained from
young and old mice on the proliferation of
glial cells in primary dissociated and trans-
plantable cultures. Extracts of the brain
from young mice had a weak (less than
2-fold) stimulatory effect on the prolifer-
ation of glial cells. In contrast, the brain
extracts obtained from aged mice had a
pronounced 3 to 4-fold stimulatory effect
(Zuev et al., 2000). The factor which stim-
ulates the proliferation of glial cells in
culture was detected in the brain tissue
of mice starting from 10 months of age.
At the same time, a similar cytoprolifer-
ative factor was also found in the blood
serum of old mice; however, it was never
detectable in the blood serum of young
animals (Zuev et al., 2005). Nevertheless,
it remained unclear whether the factor of
a detectable increase in the proliferation
of glial cells was the reason for the neu-
ronal loss or the consequence of this pro-
cess and, therefore, the process of aging
itself. To address this question, we car-
ried out experiments aimed at the artificial
aging of young mice. Four groups of ani-
mals were studied. Group No. 1 included
10 young 1.5 month-old mice which were
daily (10 injections for 2 weeks) intraperi-
toneally injected with 0.5ml of a sterile
purified brain extract obtained from the
young 1.5 month-old mice (first control).
Group No. 2 consisted of 10 naturally aged
2-year-old mice (second control). Group
No. 3 included 10 young 1.5-month old
mice which were daily (10 injections for
2 weeks) intraperitoneally injected with
0.5ml of a sterile purified brain extract
obtained from the aged 2-year-old mice.
Group number 4 consisted of 6 young
1.5-month-old mice which daily (10 injec-
tions for 2 weeks) received intraperitoneal
injections of 0.5ml of a blood serum
diluted 1: 5, which had been obtained
from the aged 2-year-old mice (Table 1).
Notably, 3 months after the beginning
of the experiment, i.e., when the ani-
mals reached 4.5 months of age, the mice
from group No. 3 were found to exhibit
some clinical manifestations of a prema-
ture aging, such as sluggish movements
and a slow reaction to food; their hair coat
looked dull and less dense with some signs
of gray on the ends of hairs. Histological
samples of the same regions of the cere-
bral cortex were prepared after removal of
the animals from the experiment. A com-
puter analyzer singled out the total area of
neurons on the standard sections of each
preparation, with the rest of the area being
occupied by the glia (Avtandilov, 2002).
As seen from Table 1, the number of neu-
rons proved to be almost 2-fold smaller
and gliosis was expressed to a greater
extent in the young animals from group
No. 3, which had received 10 injections of
the brain extract from old mice, as com-
pared with the naturally aged mice from
group No. 2. Finally, the findings of this
study indicate that the factor stimulating
the proliferation of glial cells is detected,
in addition to the brain tissue, in the
bloodstream of aging mammals. This was
supported by the results obtained in the
study of the young mice from group No.
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For many years, data have been accumu-
lated which point to a significant similarity
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Table 1 | Dimension of neuronal and glial parts in the brain-cortex of young, natural, and artificial old mice.








No 1. Ten young mice which were injected
by brain extracts from young mice
419 10.6 89.4 1.15 0.05
No 2. Ten naturally aged 2-years old mice 269 8.4 91.6 1.51 0.08
No 3. Ten young mice which were injected
by brain extracts from old mice
190 4.6 95.4 0.42 0.03
No 4. Six young mice which were injected
by blood serum from old mice
237 6.3 93.7 0.79 0.05
* - differences between indexes of neuronal areas and glial areas in groups No. 1 and No. 2 are statistical reliable (p < 0.001; t = 24.4);
- differences between indexes of neuronal areas and glial areas in groups No. 2 and No. 3 are statistical reliable (p < 0.001; t = 47.50);
- differences between indexes of neuronal areas and glial areas in groups No. 2 and No. 4 are statistical reliable (p < 0.001; t = 23.3).
4, which received the blood serum from
old animals. The mice from group No. 4
also exhibited a remarkable decrease in the
number of neurons, as well as the increase
in the proliferation of glial cells. Although
both of these indicators proved to be less
pronounced as compared with those in the
mice from group No. 3, they were at the
same time more pronounced as compared
with the naturally aged 2-year-old mice
from group No. 2.
These data suggest that a cytoprolifera-
tive factor may be present in the brain and
blood of aging mice can be regarded as a
cause of the aging process, rather than its
consequence, which gives grounds to des-
ignate it as a “factor of aging.” Detection
of the aging factor in the blood serum of
mice served as a basis for carrying out pre-
liminary studies in humans. It was found
that this factor is detected in human blood
serum starting from 25-years of age (Zuev
et al., 2005).
Study of the specific properties of the
factor havemade it possible to reveal that it
is resistant to the action of DNase, RNase,
trypsin, ultraviolet, ultrasound, and ion-
izing radiation, but highly sensitive to
the effect of proteinase K. The activity
of the factor remains constant after heat-
ing at 70◦C for 30min; however, the fac-
tor undergoes inactivation at 90◦C. Its
activity is species-specific, i.e., it mani-
fests itself only in the cells of the species,
from which the test samples are obtained
(Zuev et al., 2005). Based on this, we sup-
pose that the aging factor is a protein of
about 10 kDa, which was detected using
the Belgian dialysis bags with different
pore sizes (50, 25, 15, and 5 kDa) produced
by “Orange Scientific” (Belgium) and later
confirmed by other researchers (Villeda
et al., 2011).
In conclusion, I would like to say a
few words about the main concept—the
probability of the leading role of glio-
sis in the aging process of the brain
and, eventually, the entire organism. This
speculation should not cause surprise for
several reasons. Firstly, even in the case
of a classical prion infection, such as
scrapie, which is characterized, as it would
seem, by the primary loss of neurons
and subsequent gliosis, a direct analysis
of the sequence of events has shown that
the activation of microglia and the fol-
lowing cytokine immunoreactivity in the
course of the disease occur much ear-
lier than the development of spongiosis.
Moreover, it was found that the start of
the cytokine production, which is acti-
vated by glia, even precedes the process
of the neuronal apoptosis (Williams et al.,
1996).
Secondly, it has long been demon-
strated on the results of experimental stud-
ies in mice and rats, as well as based on
the data analysis of the autopsy mate-
rial obtained postmortem from outwardly
healthy elderly persons that in the course
of a normal aging, different elements
of glial cells, particularly astrocytes, are
characterized by an increased prolifera-
tive activity and cell hypertrophy. At the
same time, the authors emphasize that the
beginning of the so-called reactive gliosis
is characteristic of the early stages of the
aging process (Masters et al., 1985; Giese
et al., 1998; Cotrina and Nedergaard, 2002;
Deng et al., 2006).
As of today we do not have enough evi-
dence knowledge to answer the question
what causes or stimulates a cytokine pro-
duction and more studies should be con-
ducted to establish a definitive nature of
these factors.
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